Kurzfassung

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficiacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia